Development and in vitro proof-of-concept of interstitially targeted zinc-phthalocyanine liposomes for photodynamic therapy

Current Medicinal Chemistry

Volumn 21, Issue 3, 2014, Pages 377-391

  Broekgaarden, M ^a,b   De Kroon, A I P M ^b   Van Gulik, T M ^a   Heger, M ^a,b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Extrahepatic cholangiocarcinoma; Fluorescence spectroscopy and flow cytometry; Liposomal drug delivery system; Molecular probes and model proteins; Oxidation reactions; Sk Cha1 human cancer cell line

Indexed keywords

CALCEIN; DICHLORODIHYDROFLUORESCEIN; LIPID; LIPOSOME; MACROGOL; PHTHALOCYANINE ZINC; REACTIVE OXYGEN METABOLITE; TRYPTOPHAN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CARCINOMA CELL; CELL DEATH; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; MITOCHONDRION; MOLECULAR WEIGHT; NECROSIS; OXIDATION; OXIDATION REDUCTION POTENTIAL; PARTICLE SIZE; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTON CORRELATION SPECTROSCOPY; PROTEIN METABOLISM; STAINING; ZETA POTENTIAL;

CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; HUMANS; INDOLES; LIPOSOMES; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; OXIDATION-REDUCTION; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; REACTIVE OXYGEN SPECIES;

EID: 84893227609     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990211     Document Type: Article

References (59)

1. Dolmans, D.E.J.G.; Fukumora, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003, 3, 380-387.
2. Castano, A.P.; Mroz, P.; Hamblin, M.R. Photodynamic therapy and anti-tumour immunity. Nat. Rev. Cancer, 2006, 6, 535-545.
3. Triesscheijn, M.; Baas, P.; Schellens, J.H.M.; Stewart, F.A. Photodynamic therapy in oncology. Oncologist, 2006, 11, 1034-1044.
4. Wildeman, M.; Nyst, H.; Karakullukcu, B.; Bing, T. Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer. Head Neck Oncol., 2009, 1, 40.
5. Sun Z.Q. Photodynamic therapy of nasopharyngeal carcinoma by argon or dye laser - an analysis of 137 cases. Zhongua Zhong Liu Za Zhi, 1992, 14, 290-292.
6. Pinthus, J.H.; Bogaards, A.; Weersink, R.; Wilson, B.C.; Trachtenberg, J. Photodynamic therapy of urological malignancies: past to current approaches. J. Urol., 2006, 175, 1201-1207.
7. Fayter, D.; Corbett, M.; Heirs, M.; Fox, D.; Eastwood, A. A systematic review of photodynamic therapy in the treatment of precancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin. Health Technol. Assess., 2010; 14, 1-288.
8. Khan, S.A.; Thomas, H.C.; Davidson, B.R.; Taylor-Robinson, S.D. Cholangiocarcinoma. Lancet, 2005, 366, 1303-1314.
9. Ortner, M.E.J.; Caca, K.; Berr, F.; Liebetruth, J.; Mansmann, U.; Huster, D.; Voderholzer, W.; Schachschal, G.; Mössner, J.; Lochs, H.; Succesful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology, 2003, 125, 1355-1363.
10. Tomizawa, Y.; Tian, J. Photodynamic therapy for unresectable cholangiocarcinoma. Digest. Dis. Sci., 2012, 57, 274-284.
11. O'Connor, A.E.; Gallagher, W.M.; Byrne, A.T. Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem. Photobiol., 2009, 85, 1053-1074.
12. Oku, N.; Namba, Y.; Okada, S. Tumor accumulation of novel RESavoiding liposomes. Biochem. Biophys. Acta, 1992, 1126, 255-260.
13. Oku, N.; Saito, N.; Namba, Y.; Tsukada, H.; Dolphin, D.; Okada, S. Application of long-circulating liposomes to cancer photodynamic therapy. Biol. Pharm. Bull., 1997, 20, 670-673.
14. Fang, J.; Nakamura, H.; Maeda, H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv. Drug Deliv. Rev., 2011, 63, 136-151.
15. Richter, A.M. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model. Photochem. Photobiol., 1993, 57, 1000-1006.
16. Wang, Z.J.; He, Y.Y.; Huang, C.G.; Huang, J.S.; An, J.Y.; Gu, Y.; Jiang, L.J. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy. Photochem. Photobiol., 1999, 70, 773-780.
17. Oku, N.; Namba, Y.; Okada, S. Tumor accumulation of novel RESavoiding liposomes. Biochim. Biophys. Acta, 1992, 1126, 255-260.
18. Jori, G.R.; Reddi, E.; Cozzani, I.; Tomio, L. Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. Br. J. Cancer, 1986, 53, 615-621.
19. Lasch, J.; Weissig, V.; Brandl, M. Preparation of liposomes. In: Liposomes; Torchilin, V.P.; Weissig, V. Oxford University Press: New York, 2003, 3-29.
20. Rouser, G.; Fleischer, S.; Yamamoto, A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids, 1970, 5, 494-496.
21. Kloek, J.J.; Marechal, X.; Roelofsen, J.; Houtkooper, R.H.; van Kuilenberg, A.B.; Kulik, W.; Bezemer, R.; Neviere, R.; van Gulik, T.M.; Heger, M. Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion. Antiox. Redox. Signal., 2012, 17, 1109-1123.
22. Aguilar, G.; Choi, B.; Broekgaarden, M.; Yang, O.; Yang, B.; Ghasri, P.; Chen, J.K.; Bezemer, R.; Nelson, J.S.; van Drooge, A.M.; Wolkerstorfer, A.; Kelly, K.M.; Heger, M. An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains. Ann. Biomed. Eng., 2012, 40, 486-506.
23. Davies, K.J. Protein damage and degradation by oxygen radicals. I. general aspects. J. Biol. Chem., 1987, 40, 9895-9901.
24. Silvester, J.A.; Timmins, G.S.; Davies, M.J. Photodynamically generated bovine serum albumin radicals: evidence for damage transfer and oxidation at cysteine and tryptophan residues. Free Radic. Biol. Med., 1998, 24, 754-766.
25. Heger, M.; Salles, I.I.; van Vuure, W.; Hamelers, I.H.; de Kroon, A.I.; Deckmyn, H.; Beek, J.F. On the interaction of fluorophoreencapsulating PEGylated lecithin liposomes with hamster and human platelets. Microvasc. Res., 2009, 78, 57-66.
26. Knuth, A.; Gabbert, H.; Dippold, W.; Klein, O.; Sachsse, W.; Bitter-Suermann, D.; Prellwitz, W.; Meyer zum Büschenfelde, K.H. Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J. Hepatol., 1985, 1, 579-596.
27. Altman, D.G.; Bland, J.M. Measurement in medicine: the analysis of method comparison studies. J. Royal Stat. Soc. D. (The Statistician), 1983, 32, 307-317.
28. Nunes, S.M.T.; Sguilla, F.S.; Tedesco, A.C. Photophysical studies of zinc phthalocyanine and chloroaluminum phthalocyanine incorporated into liposomes in the presence of additives. Braz. J. Med. Biol. Res., 2004, 37, 273-284.
29. Mroz, P.; Hashmi, J.T.; Huang, Y.Y.; Lange, N.; Hamblin, M.R. Stimulation of anti-tumour immunity by photodynamic therapy. Exp. Rev. Clin. Immunol., 2011, 7, 75-91.
30. Valduga, G.; Nonell, S.; Reddi, E.; Jori, G.; Braslavsky, S.E. The production of singlet molecular oxygen by zinc(II) phthalocyanine in ethanol and in unilamellar vesicles. Chemical quenching and phosphorescence studies. Photochem. Photobiol., 1988, 48, 1-5.
31. Niki, E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic. Biol. Med., 2009, 49, 469-484.
32. Allen, T.M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta, 1991, 1066, 29-36.
33. Urizzi, P.; Allen, C.M.; Langlois, R.; Ouellet, R.; la Madeleine, C.; van Lier, J.E. Low-density lipoprotein-bound aluminum sulfophthalocyanine: targeting tumor cells for photodynamic therapy. J. Porphyrins Phthalocyanines, 2001, 5, 154-160.
34. Rück, A.; Beck, G.; Bachor, R.; Akgün, N.; Gschwend, M.H.; Steiner, R. Dynamic fluorescence changes during photodynamic therapy in vivo and in vitro of hydrophilic Al(III) phthalocyanine tetrasulfonate and lipophilic Zn(II) phthalocyanine administered in liposomes. J. Photochem. Photobiol. B., 1996, 36, 127-315.
35. Immordino, M.L.; Dosio, F.; Cattel, L. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int. J. Nanomed., 2006, 1, 297-315.
36. Namba, Y.; Sakakibara, T.; Masada, M.; Ito, F.; Oku, N. Glucoronate- modified liposomes with prolonged circulation time. Chem. Pharm. Bull., 1990, 38, 1663-1666.
37. Immordino, M.L.; Brusa, P.; Arpicco, S.; Stella, B.; Dosio, F.; Cattel, L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J. Control. Release, 2003, 91, 417-429.
38. Ishida, O.; Maruyama, L.; Sasaki, K.; Iwatsuru, M.; Size-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing mice. Int. J. Pharm., 1999, 190, 49-56.
39. Tanielian, C.; Heinrich, G. Effect of aggregation on the hematoporphyrin- sensitized production of singlet molecular oxygen. Photochem. Photobiol., 1995, 61, 131-135.
40. Damoiseau, X.; Schuitemaker, H.J.; Lagerberg, J.W.; Hoebeke, M. Increase of the photosensitizing efficiency of the bacteriochlorin a by liposome-incorporation. J. Photochem. Photobiol. B., 2001, 60, 50-60.
41. Isele, U.; van Hoogevest, P.; Hilfiker, R.; Capraro, H.G.; Schieweck, K.; Leuenberger, H. Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents. J. Pharm. Sci., 1994, 83, 1608-1616.
42. Isele, U.; Schieweck, K.; Kessler, R.; van Hoogevest, P.; Capraro, H.G. Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumor-bearing mice: influence of aggregation state, particle size, and composition. J. Pharm. Sci., 1995, 84, 166-173.
43. Mroz, P.; Szokalska, A.; Wu, M.X.; Hamblin, M.R. Photodynamic therapy can lead to development of systemic antigen-specific immune response. PLoS ONE, 2010, 14, e15194.
44. Garg, A.D.; Krysko, D.; Vandenabeele, P.; Agostinis, P. DAMPs and PDT-mediated phot-oxidative stress: exploring the unknown. Photochem. Photobiol. Sci., 2011, 10, 670-680.
45. Garg, A.D.; Krysko, D.V.; Verfaillie, T.; Kaczmarek, A.; Ferreira, G.B.; Marysael, T.; Rubio, N.; Firczuk, M.; Mathieu, C.; Roebroek, A.J.; Annaert, W.; Golab, J.; de Witte, P.; Vandenabeele, P.; Agostinis, P. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO. J., 2012, 61, 1062-1079.
46. Garg, A.D.; Krysko, D.V.; Vandenabeele, P.; Agostinis, P. Hypericin- based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol. Immunother., 2012, 61, 215-221.
47. Korbelik, M.; Zhang, W.; Merchant, S. Involvement of damageassociated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunol. Immunother., 2011, 60, 1431-1437.
48. Ricchelli, F. Interaction of phthalocyanines with lipid membranes: a spectroscopic and functional study on isolated rat liver mitochondria. Biochim. Biophys. Acta, 1994, 1196, 165-171.
49. Alexandratou, E.; Yova, D.; Loukas, S. A confocal microscopy study of the very early cellular response to oxidative stress induced by zinc phthalocyanine photosensitization. Free Radic. Biol. Med., 2005, 39, 1119-1127.
50. Margaron, P.; Grégoire, M.J.; Scasnár, V.; Ali, H.; van Lier, J.E. Structure-photodynamic activity relationships of a series of 4- substituted zinc phthalocyanines. Photochem. Photobiol., 1996, 63, 217-223.
51. Moserova, I.; Kralova, I. Role of the ER stress response in photodynamic therapy: ROS generated in different subcellular compartments trigger diverse cell death pathways. PLoS ONE, 2012, 7, e32972.
52. Edmonds, C.; Hagan, S.; Gallagher-Colombo, S.M.; Busch, T.M.; Cengel, K.A. Photodynamic therapy activated signaling from epidermal growth factor receptor and STAT3: targeting survival pathways to increase PDT efficacy in ovarian and lung cancer. Cancer Biol. Ther., 2012, 13, 1463-1470.
53. Casas, A.; Di Venosa, G.; Hasan, T.; Al Battle. Mechanisms of resistance to photodynamic therapy. Curr. Med. Chem., 2011, 18, 2486-2515.
54. Mueller, M.M.; Fusenig, N.E. Friends or foes: bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer, 2004, 4, 839-849.
55. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420, 860-867.
56. Sadzuka, Y.; Iwasaki, F.; Sugiyama, I.; Horiuchi, K.; Hirano, T.; Ozawa, H.; Kanayama, N.; Oku, N. Phototoxicity of coproporphyrin as a novel photodynamic therapy was enhanced by liposomalization. Toxicol. Lett., 2008, 182, 110-114.
57. Sadzuka, Y.; Tokutomi, K.; Iwasaki, F.; Sugiyama, I.; Hirano, T.; Konno, H.; Oku, N.; Sonobe, T. The phototoxicity of photofrin was enhanced by PEGylated liposome in vitro. Cancer Lett., 2006, 241, 42-48.
58. Fahr, A.; van Hoogevest, P.; May, S.; Bergstrand, N.; S Leigh, M.L. Transfer of lipophilic drugs between liposomal membranes and biological interfaces: consequences for drug delivery. Eur. J. Pharm. Sci., 2005, 26, 251-265.
59. Fahr, A.; van Hoogevest, P.; Kuntsche, J.; Leigh M.L. Lipophilic drug transfer between liposomal and biological membranes: what does it mean for parenteral and oral drug delivery? J. Liposome Res., 2006, 16, 281-301.